Correction

In Minerva published 20 June 2024 (doi:10.1136/bmj.q1296) the item “Stopping valproate” erroneously reported that guidelines recommend restricting the use of valproate to men and women under 55 because of the drug’s teratogenicity. The correct statement is that guidelines recommend restricting use of valproate to men and women over 55. The article has been corrected online (https://www.bmj.com/content/385/bmj.q1296).

Source link

  • Share this post

Leave a Comment